Skip to main content
GutCited
Figure 2

Descrição

Gut microbiota alpha diversity metrics, including Shannon index and observed species richness, are compared before and after butyrate supplementation. Changes in diversity differ between Crohn's disease and ulcerative colitis subgroups.

More Figures from This Paper

Beta diversity analysis using principal coordinates reveals shifts in overall microbiota community structure following butyrate supplementation. Separation between pre- and post-treatment samples suggests reproducible compositional changes.

Figure 3

Beta diversity analysis using principal coordinates reveals shifts in overall microbiota community structure following butyrate supplementation. Separation between pre- and post-treatment samples suggests reproducible compositional changes.

chart

Figure 2

Chart
663 × 318px · 179,9 KB

Source Paper

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.

Neurogastroenterology and motility (2020)

PMID: 32476236

DOI: 10.1111/nmo.13914

Cite This Figure

![Figure 2: Gut microbiota alpha diversity metrics, including Shannon index and observed species richness, are compared before and after butyrate supplementation. Changes in diversity differ between Crohn's disease and ulcerative colitis subgroups.](https://pdfs.citedhealth.com/figures/32476236/589.png)

> Source: Sonia Facchin et al. "Microbiota changes induced by microencapsulated sodium butyrate in patients with." *Neurogastroenterology and motility*, 2020. PMID: [32476236](https://pubmed.ncbi.nlm.nih.gov/32476236/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/32476236/589.png" alt="Gut microbiota alpha diversity metrics, including Shannon index and observed species richness, are compared before and after butyrate supplementation. Changes in diversity differ between Crohn's disease and ulcerative colitis subgroups." />
  <figcaption>Figure 2. Gut microbiota alpha diversity metrics, including Shannon index and observed species richness, are compared before and after butyrate supplementation. Changes in diversity differ between Crohn's disease and ulcerative colitis subgroups.<br>  Source: Sonia Facchin et al. "Microbiota changes induced by microencapsulated sodium butyrate in patients with." <em>Neurogastroenterology and motility</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32476236/">32476236</a></figcaption>
</figure>

Evidências Relacionadas

C
Butyrate (Sodium/Calcium Butyrate) para Ulcerative Colitis (UC)

Nota C · 3 estudos

 C
Butyrate (Sodium/Calcium Butyrate) para Crohn's Disease

Nota C · 2 estudos